3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Pancreatic Neoplasms
113
Urinary Bladder Neoplasms
56
Carcinoma, Non-Small-Cell Lung
52
Cholangiocarcinoma
33
Biliary Tract Neoplasms
32
Neoplasm Metastasis
30
Ovarian Neoplasms
27
Lymphoma, Large B-Cell, Diffuse
26
Breast Neoplasms
25
Lung Neoplasms
24
Neoplasms
23
Carcinoma, Transitional Cell
23
Triple Negative Breast Neoplasms
22
Nasopharyngeal Carcinoma
21
Colorectal Neoplasms
20
Recurrence
17
Non-Muscle Invasive Bladder Neoplasms
16
Gallbladder Neoplasms
15
Fallopian Tube Neoplasms
15
Sarcoma
13
Bile Duct Neoplasms
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Hodgkin Disease
10
Lymphoma
9
Uterine Cervical Neoplasms
8
Adenocarcinoma
8
Stomach Neoplasms
7
Lymphoma, Non-Hodgkin
7
Endometrial Neoplasms
7
Nasopharyngeal Neoplasms
6
Interventions
aldesleukin
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Brachytherapy
2
Adoptive Transfer
2
zimberelimab
1
trastuzumab deruxtecan
1
talazoparib
1
liposomal doxorubicin
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
belzutifan
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Specimen Handling
1
Sonazoid
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Paclitaxel
1
Observation
1
Nivolumab
1
Methods
1
Interviews as Topic
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Educational Status
1
Early Intervention, Educational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vaginal Neoplasms
×
Gemcitabine
×
1 year
×
Clear all
NCT06023862
2026-05-06
DOVE
Yonsei University
Phase 2
Recruiting
198 enrolled